Palisade Bio Inc (NASDAQ:PALI) has a beta value of 1.32 and has seen 9.1 million shares traded in the recent trading session. The company, currently valued at $2.42M, closed the recent trade at $0.88 per share which meant it lost -$0.06 on the day or -6.89% during that session. The PALI stock price is -996.59% off its 52-week high price of $9.65 and 14.77% above the 52-week low of $0.75. If we look at the company’s 10-day average daily trading volume, we find that it stood at 70920.0 shares traded. The 3-month trading volume is 1.61 million shares.
The consensus among analysts is that Palisade Bio Inc (PALI) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -1.99.
Palisade Bio Inc (NASDAQ:PALI) trade information
Sporting -6.89% in the red today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the PALI stock price touched $0.88 or saw a rise of 13.7%. Year-to-date, Palisade Bio Inc shares have moved -46.96%, while the 5-day performance has seen it change 6.28%. Over the past 30 days, the shares of Palisade Bio Inc (NASDAQ:PALI) have changed -24.55%. Short interest in the company has seen 0.15 million shares shorted with days to cover at 0.96.
Wall Street analysts have a consensus price target for the stock at $1.5, which means that the shares’ value could jump 41.33% from the levels at last check today. The projected low price target is $1.5 while the price target rests at a high of $1.5. In that case, then, we find that the latest price level in today’s session is -70.45% off the targeted high while a plunge would see the stock gain -70.45% from the levels at last check today.
Palisade Bio Inc (PALI) estimates and forecasts
The company’s shares have lost -75.55% over the past 6 months. Revenue growth from the last financial year stood is estimated to be -100.00%.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 75.28% over the past 5 years. Earnings growth for 2025 is a modest 56.80% while over the next 5 years, the company’s earnings are expected to increase by 52.91%.
PALI Dividends
Palisade Bio Inc is expected to release its next earnings report on 2024-Nov-11 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Palisade Bio Inc (NASDAQ:PALI)’s Major holders
Insiders own 0.80% of the company shares, while shares held by institutions stand at 7.20% with a share float percentage of 7.26%. Investors are also buoyed by the number of investors in a company, with Palisade Bio Inc having a total of 9.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund. As of Dec 31, 2024, the former fund manager holds about 0.23% shares in the company for having 6.29 shares of worth $5624.0 while later fund manager owns 4.54 shares of worth $4056.0 as of Dec 31, 2024, which makes it owner of about 0.16% of company’s outstanding stock.
